Spinal Tech

In 2015, Medtech was involved in merger and acquisition activity as well as several transactions over $1 billion in value.

Paradigm Spine, a New York-based developer of lumbar spinal stenosis treatment solutions, published "Evaluation of Decompression and Interlaminar Stabilization Compared with Decompression and Fusion for the Treatment of Lumbar Spinal Stenosis: 5-year Follow-up of a Prospective, Randomized, Controlled Trial."

Israel-based ReWalk Robotics published the first case study of its ReWalk robotic exoskeleton in Spinal Cord Series and Cases, according to CNN Money. The study involved a patient who used the device for six months.

JPMorgan Chase restated Smith & Nephew stock's "neutral" rating, according to IRA Market Report.

Polyganics, a Netherlands-based medical technology company, received FDA clearance for its device that decreases neuroma formation, according to Plastics Today.

Stryker reported strong organic net sales in 2015 as well as a net sales increase in the fourth quarter.

A Minnesota appeals court revived the Medtronic shareholders' lawsuit against the company's merger with Covidien, according to a MedCity News report.

Stryker Vice President and CFO William R. Jellison will retire from his post after three years with the company.

BionX Medical Technologies completed a Series E funding round.

Acquisition helps CTL Medical Corporation enhance its Medical Device Manufacturing Practice.